Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesA novel LCD (coal tar) solution for psoriasis does not discolor naturally light or color-processed hair in an exaggerated exposure test model
Journal of Cosmetic Dermatology, 09/14/09
Johnson C et al. – LCD solution did not discolor naturally light or color–processed hair following repeated exposures and 24 h submergence. The marketed LCD solution does not appear to discolor naturally light or color–processed hair.
Barbara Green, 09/14/09
| Scalp psoriasis is very common among psoriasis sufferers and difficult to treat. Psorent is a coal tar containing solution that is very effective (it outperformed calcipotriol cream on moderate psoriasis) and its aesthetics are highly patient acceptable (study results pending publication: Am J Clin Dermatol). Psorent’s fast-absorbing solution vehicle makes it a good treatment option for use on the scalp. We’re happy that the results of our study indicated no staining of light and color-processed hair making it a viable treatment alternative for scalp psoriasis. |
Related Articles
Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09
Relevance Score: 95%
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 91%
Study shows major burden of psoriasis
Internet Source, 10/29/09
Relevance Score: 91%
Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 91%
Why nail psoriasis remains difficult to treat
Dermatology in Practice, 10/12/09
Relevance Score: 91%
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis
International Journal of Dermatology, 11/25/09
Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life
Clinical and Experimental Dermatology, 11/25/09
Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis
Journal of the European Academy of Dermatology and Venereology, 11/24/09
Sponsor
Article Search
Sponsor